Sector pending / Pharmaceutical PreparationsUpdated 2026-05-10 22:07 UTC

FRA/TEV stock hub

FRA/TEV has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

FRA/TEVis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

35.3B

Frankfurt Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

FRA/TEV

In the news

Latest news · FRA/TEV

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E14.6

P25 n/aP50 n/aP75 n/a

Trailing P/E26

P25 n/aP50 n/aP75 n/a

ROE21.6

P25 n/aP50 n/aP75 n/a

ROIC18.6

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All FRA/TEV market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

201

Groups with data

Currency

USD

Showing 201 of 201 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Israel
Country code	DE
Employees	32,008
Employees Change	-2,844%
Employees Change Percent	-7.97
Enterprise value	EUR 46.6B
Exchange	Frankfurt Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Pharmaceutical Preparations
Last refreshed	2026-05-10
Market cap	EUR 35.3B
Price	EUR 30.6
Price currency	EUR
Rev Per Employee	470,094.59x
Sic	2834
Symbol	fra/TEV
Website	https://www.tevapharm.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	3.84%
EV Earnings	34.3x
EV/EBIT	13.63x
EV/EBITDA	10.64x
EV/FCF	45.8x
EV/Sales	3.16x
FCF yield	2.88%
Forward P/E	14.57x
P/B ratio	4.95x
P/E ratio	26.04x
P/S ratio	2.35x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	23.09%
EBITDA Margin	28.84%
FCF margin	6.76%
Gross margin	52.06%
Gross Profit	EUR 7.8B
Gross Profit Growth	10.56%
Gross Profit Growth Q	5.01%
Gross Profit Growth3 Y	9.84%
Gross Profit Growth5 Y	3.67%
Net Income	EUR 1.4B
Net Income Growth Q	72.43%
Pretax Margin	7.95%
Profit Margin	9.02%
Profit Per Employee	EUR 42,406
ROA	6.38
Roa5y	4.67
ROCE	15.11
ROE	21.6
Roe5y	-7.19
ROIC	18.63
Roic5y	12.12

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-3.34%
Cagr15y	0.54%
Cagr1y	109.7%
Cagr3y	57.57%
Cagr5y	29.08%
Div CAGR10	-4.66%
EPS Growth Q	72.22
FCF Growth	53.2%
FCF Growth3 Y	6.73%
OCF Growth	35.39%
OCF Growth10 Y	-11.11%
OCF Growth3 Y	4.69%
OCF Growth5 Y	27.64%
Revenue Growth	4.41x
Revenue Growth Q	2.34x
Revenue Growth3 Y	5.14x
Revenue Growth5 Y	1.28x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.44
Assets	EUR 34.7B
Cash	EUR 3.2B
Current Assets	EUR 11.6B
Current Liabilities	EUR 11.5B
Debt	EUR 14.7B
Debt EBITDA	EUR 3.29
Debt Equity	EUR 2.06
Debt FCF	EUR 14.44
Equity	EUR 7.1B
Interest Coverage	4.48
Liabilities	EUR 27.6B
Long Term Assets	EUR 23.1B
Long Term Liabilities	EUR 16.1B
Net Cash	EUR -11.4B
Net Cash By Market Cap	EUR -32.35
Net Debt EBITDA	EUR 2.64
Net Debt Equity	EUR 1.6
Net Debt FCF	EUR 11.25
Tangible Book Value	EUR -9.7B
Tangible Book Value Per Share	EUR -8.34

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.01
Inventory Turnover	2.59
Net Working Capital	EUR -824.8M
Quick ratio	0.53
Working Capital	EUR 154.4M
Working Capital Turnover	EUR 54.82

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-2.93%
Dividend per share	EUR 0
Last Dividend	EUR 0.06

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-28.77%
1Y total return	109.59%
200-day SMA	22.27
3Y total return	291.3%
50-day SMA	26.79
50-day SMA vs 200-day SMA	50over200
5Y total return	258.31%
All Time High	65.73
All Time High Change	-53.45%
All Time High Date	2015-08-05
All Time Low	5.52
All Time Low Change	454.35%
All Time Low Date	2019-08-15
ATR	1.04
Ch YTD	15.91
High	30.7
High52	31.6
High52 Date	2026-05-06
High52ch	-3.16%
Low	30.2
Low52	12.9
Low52 Date	2025-08-01
Low52ch	137.21%
Ma50ch	14.21%
Price vs 200-day SMA	37.39%
RSI	67.66
RSI Monthly	73.02
RSI Weekly	68.41
Sharpe ratio	1.56x
Sortino ratio	3.19
Total Return	-2.93%
Tr YTD	15.91
Tr15y	8.4%
Tr1m	22.4%
Tr1w	0.66%
Tr3m	5.16%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR 3.5B
Operating Income Growth	17.07
Operating Income Growth Q	7.62
Operating Income Growth3 Y	17.08
Operating Income Growth5 Y	6.92
Operating margin	23.09

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1,083,200,880%
Net Borrowing	-397,694,178
Shares Qo Q	0.51%
Shares Yo Y	2.93%
Short Ratio	4.31

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR 872.5M
Average Volume	1,419.4x
Bv Per Share	6.13
CAPEX	EUR -470.1M
Ch10y	-32.04
Ch15y	-7.06
Ch1m	22.4
Ch1w	0.66
Ch1y	109.6
Ch3m	5.16
Ch3y	291.3
Ch5y	258.3
Ch6m	50
Change	-0.65%
Change From Open	0.99
Close	30.8
Days Gap	-1.62
Depreciation Amortization	845,418,114
Dollar Volume	7,344
Earnings Date	2026-04-29
EBIT	EUR 3.5B
EBITDA	EUR 4.3B
EPS	EUR 1.16
F Score	7
FCF	EUR 1B
FCF EV Yield	2.18x
Financing CF	-341,716,200
Fiscal Year End	December
Founded	1,901
Goodwill	13,416,454,764
Graham Number	12.78298
Graham Upside	-58.23
Income Tax	EUR -162.2M
Investing CF	663,484,500
Is Primary Listing	0
Last Earnings Date	2026-04-29
Last Report Date	2026-03-31
Ma150	24.62
Ma150ch	24.29%
Ma20	27.83
Ma20ch	9.97%
Net CF	1,772,761,200
Open	30.3
P FCF Ratio	34.77
P OCF Ratio	23.78
Position In Range	80
Ppne	3,674,219,346
Price Date	2026-05-08
Price EBITDA	EUR 8.15
Relative Volume	0.17x
Revenue	15,046,787,700x
SBC By Revenue	0.96x
Share Based Comp	143,971,800
Tax By Revenue	-1.08x
Tr6m	50%
Volume	240
Z Score	0.79

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does FRA/TEV pay a dividend?

Capital-return profile for this ticker.

Performance

FRA/TEV stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns FRA/TEV?

Insider, institutional, and short-interest positioning.

Institutional ownership

n/a

Share of float held by funds and institutions

Insider ownership

n/a

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

FRA/TEV momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

67.7

Neutral momentum band

Price vs 200-day MA

+37.4%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

1.56

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About FRA/TEV

Hub-level FAQ points readers to the deeper analysis pages.

What is the current fra/TEV stock rating?

fra/TEV is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full fra/TEV analysis?

The full report lives at /stocks/fra/TEV/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for fra/TEV?

The latest report frames fra/TEV around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the fra/TEV page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.